BRCA1 & BRCA2 Genetic Testing in India: Importance, Process, and Cost (2026 Guide)
Written by: Dr. Ananya Sharma, Medical Geneticist | Medically Reviewed by: Dr. Rajesh Kumar, Oncologist | Last Updated: February 2026
At a Glance: BRCA1 & BRCA2 Genetic Test
- Sample Required: Blood (EDTA) or Saliva (Oragene)
- Fasting Rules: No fasting required
- Turnaround Time (TAT): 10–14 business days
- Base Cost: [Insert Current 2026 Price]
Why BRCA Testing Matters in 2026
Breast cancer remains the most common cancer among women globally, with an estimated 2.4 million new cases in 2025. In India, the incidence is rising, and hereditary factors account for 5–10% of all breast and ovarian cancers. The BRCA1 and BRCA2 genes are the most well-known tumor suppressor genes associated with hereditary breast and ovarian cancer syndrome (HBOC).
Genetic testing for BRCA mutations is no longer a luxury—it is a critical tool for risk assessment, early detection, and personalized treatment. This guide explains the science, the procedure, and the clinical implications of BRCA testing, with a focus on the Indian context.
Understanding BRCA1 and BRCA2 Genes
BRCA1 (Breast Cancer gene 1) and BRCA2 (Breast Cancer gene 2) are tumor suppressor genes that produce proteins responsible for repairing damaged DNA. When these genes contain harmful mutations, the body's ability to repair DNA is compromised, leading to an increased risk of breast, ovarian, prostate, and pancreatic cancers.
These mutations are inherited in an autosomal dominant pattern, meaning a single copy of the mutated gene from either parent is sufficient to increase cancer risk.
| Gene | Function | Associated Cancer Risks |
|---|---|---|
| BRCA1 | DNA double-strand break repair, cell cycle checkpoint | Breast (up to 72%), Ovarian (up to 44%), Pancreatic, Prostate |
| BRCA2 | DNA repair via homologous recombination | Breast (up to 69%), Ovarian (up to 17%), Pancreatic, Prostate, Melanoma |
Hereditary vs. Sporadic Cancer
Most cancers are sporadic, meaning they occur due to acquired mutations over a lifetime. Hereditary cancers are caused by inherited germline mutations. The distinction is crucial for risk management and family counseling.
| Feature | Sporadic Cancer | Hereditary Cancer |
|---|---|---|
| Cause | Acquired mutations, environmental factors | Inherited germline mutations (e.g., BRCA1/2) |
| Age of Onset | Typically later (60+ years) | Earlier (often <50 years) |
| Family History | Usually absent | Often present (multiple relatives, bilateral disease) |
| Risk to Relatives | Minimal | 50% chance of inheriting the mutation |
Who Should Consider BRCA Testing?
Genetic testing is not for everyone. The following criteria, based on NCCN guidelines, indicate a higher likelihood of carrying a BRCA mutation:
- Diagnosed with breast cancer at age 50 or younger
- Triple-negative breast cancer diagnosed at age 60 or younger
- Ovarian cancer at any age
- Male breast cancer
- Two or more primary breast cancers (bilateral or ipsilateral)
- Known BRCA mutation in a family member
- Ashkenazi Jewish ancestry with a personal or family history of breast/ovarian cancer
- Family history of breast cancer in multiple relatives across generations
BRCA Test Procedure: What to Expect
At DNA Labs India, BRCA testing is performed using Next-Generation Sequencing (NGS) technology, which provides comprehensive analysis of both BRCA1 and BRCA2 genes, including large rearrangements. The process is simple:
- Sample Collection: A blood sample (EDTA) or saliva sample is collected at our collection centers or via home collection.
- Laboratory Analysis: DNA is extracted and sequenced using NGS. The entire coding regions and splice sites are analyzed.
- Variant Classification: Detected variants are classified as pathogenic, likely pathogenic, benign, or VUS (Variant of Uncertain Significance) based on ACMG guidelines.
- Report Generation: A comprehensive report is issued within 10–14 business days, including clinical recommendations.
No fasting is required, and the test can be done at any time of day.
Interpreting BRCA Test Results
Understanding your results is critical. Here’s what each outcome means:
| Result Type | Meaning | Clinical Action |
|---|---|---|
| Positive (Pathogenic) | A harmful mutation is present, increasing cancer risk. | Enhanced screening, risk-reducing surgery, PARP inhibitor therapy if cancer is present. |
| Negative (No mutation) | No pathogenic variant detected. If a family mutation is known, this is a true negative. | Standard population screening recommendations apply. |
| VUS (Variant of Uncertain Significance) | A genetic change with unknown impact on cancer risk. | Follow-up with genetic counseling; reclassification may occur over time. |
Clinical Implications and Management
For individuals with a pathogenic BRCA mutation, proactive management can significantly reduce cancer risk and mortality. Options include:
- Enhanced Surveillance: Annual breast MRI and mammography starting at age 25, and ovarian screening (though less effective).
- Risk-Reducing Surgery: Prophylactic bilateral mastectomy and salpingo-oophorectomy can reduce risk by over 90%.
- Chemoprevention: Tamoxifen or raloxifene for breast cancer risk reduction.
- Targeted Therapy: PARP inhibitors (e.g., olaparib) are effective in treating BRCA-mutated cancers.
Why Choose DNA Labs India for BRCA Testing?
DNA Labs India is an ISO 9001 certified laboratory committed to accurate and affordable genetic testing. Our BRCA panel includes:
- Comprehensive NGS analysis of BRCA1 and BRCA2, including large rearrangements.
- Rapid turnaround time of 10–14 business days.
- Genetic counseling support before and after testing.
- 100% confidential and secure handling of genetic data.
Frequently Asked Questions (FAQs)
Who should get BRCA testing?
Individuals with a personal or family history suggestive of hereditary breast and ovarian cancer, as per the criteria listed above.
Is BRCA testing covered by insurance?
Coverage varies; many Indian insurers now cover genetic testing for high-risk individuals. Check with your provider.
What is the turnaround time?
Typically 10–14 business days from sample receipt.
Can I get tested without a doctor's referral?
Yes, but we strongly recommend genetic counseling to interpret results and make informed decisions.
Conclusion: Take Control of Your Genetic Health
BRCA testing is a powerful tool for cancer prevention and personalized treatment. If you have a family history of breast or ovarian cancer, consult a medical geneticist to assess your risk. DNA Labs India offers reliable, ISO 9001 certified BRCA testing with comprehensive support.
Book your test today. Early knowledge saves lives.